Allosteric modulation of [3H]gabapentin binding by ruthenium red

Neuropharmacology

Volumn 39, Issue 7, 2000, Pages 1267-1273

  Taylor, Michele T ^a   Bonhaus, Douglas W ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

Gabapentin; MgCl2; Ruthenium red; Spermine; Voltage gated calcium channel

Indexed keywords

CAFFEINE; CALCIUM CHANNEL; CALCIUM CHANNEL AFFECTING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CAPSAZEPINE; DIZOCILPINE; GABAPENTIN; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIC; RUTHENIUM RED; RYANODINE; SPERMINE;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION; DRUG MECHANISM; ENZYME KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETIC ACIDS; AMINES; ANIMALS; ANTICONVULSANTS; BINDING SITES; BINDING, COMPETITIVE; CALCIUM CHANNELS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; LIGANDS; MAGNESIUM CHLORIDE; MEMBRANES; MICE; RUTHENIUM RED; SPERMINE; TEMPERATURE;

EID: 0034064847     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00198-7     Document Type: Article

References (29)

1. Alden K., Garcia J. Differential effects of gabapentin on calcium currents from neuronal and muscle cells. Biophysics Journal. 75:1999;A90.
2. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. Journal of the American Medical Association. 280:1998;1831-1836.
3. Bergey G.K., Morris H.H., Rosenfeld W., Blume W.T., Penovich P.E., Morrell M.J., Leiderman D.B., Crockatt J.G., LaMoreaux L., Garofalo E., Pierce M. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89. Neurology. 49:1997;739-745.
4. 50) of an enzymatic reaction. Biochemical Pharmacology. 92:1973;881-894.
5. Currie K.P., Fox A.P. Comparison of N- and P/Q-type voltage-gated calcium channel current inhibition. Journal of Neuroscience. 17:1997;4570-4579.
6. 2δ calcium channel subunit. British Journal of Pharmacology. 120:1997;833-840.
7. + currents. European Journal of Neuroscience. 6:1994;412-419.
8. Field M.J., Holloman E.F., McCleary S., Hughes J., Singh L. Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. Journal of Pharmacology and Experimental Therapeutics. 282:1997;1242-1246.
9. 2δ subunit of a calcium channel. Journal of Biological Chemistry. 271:1996;5768-5776.
10. Goa K.L., Sorkin E.M. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Drugs. 46:1993;409-427.
11. Gomez M., Hellstrand P. Effects of polyamines on voltage-activated calcium channels in guinea-pig intestinal smooth muscle. Pflugers Archiv - European Journal of Physiology. 430:1995;501-507.
12. Gomis A., Gutierrez L.M., Sala F., Viniegra S., Reig J.A. Ruthenium red inhibits selectively chromaffin cell calcium channels. Biochemical Pharmacology. 47:1994;225-231.
13. ++ channels. Journal of Pharmacology and Experimental Therapeutics. 273:1995;940-947.
14. 2δ subunit. Journal of Neuroscience. 19:1999;684-691.
15. 2+ in rat phaeochromocytoma cells. Journal of Physiology. 466:1993;683-706.
16. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand systems. Analytical Biochemistry. 107:1980;220-239.
17. Parness J., Palnitkar S.S. Identification of dantrolene binding sites in porcine skeletal muscle sarcoplasmic reticulum. Journal of Biological Chemistry. 270:1995;18465-18472.
18. 2+ in cultured rat cerebellar granule neurones. Pflugers Archiv - European Journal of Physiology. 425:1993;518-527.
19. Rock D.M., Kelly K.M., Macdonald R.L. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Research. 16:1993;89-98.
20. Rosenberg J.M., Harrell C., Ristic H., Werner R.A., de Rosayro A.M. The effect of gabapentin on neuropathic pain. Clinical Journal of Pain. 13:1997;251-255.
21. Rosner H., Rubin L., Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clinical Journal of Pain. 12:1996;56-58.
22. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. Journal of the American Medical Association. 280:1998;1837-1842.
23. Schumacher T.B., Beck H., Steinhauser C., Schramm J., Elger C.E. Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia. 39:1998;355-363.
24. 2+. American Journal of Physiology. 271:1996;L251-L257.
25. Stefani A., Spadoni F., Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology. 37:1998;83-91.
26. 3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. European Journal of Pharmacology. 244:1993;293-301.
27. Taylor M.T., Bonhaus D.W. Allosteric interactions between gabapentin and ruthenium red. The FASEB Journal. 12:1998;A439.
28. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research. 29:1998;233-249.
29. Taylor C.P., Vartanian M.G., Yuen P.W., Bigge C., Suman-Chauhan N., Hill D.R. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Research. 14:1993;11-15.